Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shubham Atal"'
Publikováno v:
Diabetol Int
SGLT-2 inhibitors have recently emerged as an important class of oral drugs for treatment of type 2 diabetes mellitus, especially in patients with cardiovascular or renal impairment, recommended in all recent treatment guidelines. They have additiona
Autor:
Avik Ray, Shubham Atal
Publikováno v:
Postgraduate Medical Journal. 96:500-502
We are gradually moving to a world beyond ‘p 0.05. After all, p value is a probability value and varies every time the study is repeated. We should be ready to embrace the uncertainty involved in scientific research instead of bringing in the false
Autor:
Vipul Mayank, Abhijit Pakhare, Ishan Raj Tiwari, Neelesh Shrivastava, Rajnish Joshi, Rasha Anwar, Shubham Atal, Sanjeev Kumar, Ankur Joshi, Khushbu Dubey
ObjectivesHypertension and diabetes mellitus are key risk factors for Cardiovascular diseases. Pharmacotherapy and life-style modifications are necessary. Once screened, individuals need to be linked to primary health-care system for initiation and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aeaf8ff489e5c34ff8fff45f813b7d65
https://doi.org/10.1101/2020.09.21.20198622
https://doi.org/10.1101/2020.09.21.20198622
Autor:
Rajnish Joshi, Sanjeev Kumar, Ankur Joshi, Abhijit Pakhare, Anuja Lahiri, Neelesh Shrivastava, Akash Ranjan, Sagar Khadanga, Yogesh Sabde, Vaibhav Ingle, Shubham Atal
In urban India, about 35-40% of all adults have hypertension and about 10-15% have diabetes mellitus. National Program for Prevention and Control of Diabetes, Cancer and Stroke (NPCDCS) launched by Government of India has envisaged to screen all adul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4555ada630a6ac3c52534aeb4e12ce65
https://doi.org/10.1101/2020.09.18.20189639
https://doi.org/10.1101/2020.09.18.20189639